search
Back to results

Efficacy of Behavioral Therapy and Exercise in Gestational Diabetes Mellitus (GDM)

Primary Purpose

Birth-weight

Status
Completed
Phase
Phase 3
Locations
Italy
Study Type
Interventional
Intervention
Behavioral therapy
Exercise
Behavioral therapy and exercise
Sponsored by
University of Turin, Italy
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Birth-weight focused on measuring gestational diabetes mellitus, fasting glucose, insulin resistance, birth-weight, Glucose values, Insulin concentrations, Cesarean sections

Eligibility Criteria

18 Years - 50 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Gestational age between 24 and 26 weeks
  • Diagnosis of GDM at the 75g oral glucose tolerance test (OGTT)
  • Singleton pregnancy

Exclusion Criteria:

  • Body mass index > 40 or < 12kg/m2
  • Any known diseases (pre-existing diabetes mellitus, cardiovascular diseases, liver/kidney diseases, cancers, arterial hypertension)
  • Patients on any drugs

Sites / Locations

  • University of Turin

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

No Intervention

Experimental

Experimental

Experimental

Arm Label

Diet alone

Behavioral therapy

Exercise

Behavioral therapy and exercise

Arm Description

Outcomes

Primary Outcome Measures

Serum fasting glucose values.
To investigate changes from baseline in serum fasting glucose values in each arm with a 2x2 factorial design.

Secondary Outcome Measures

Serum fasting insulin values
To investigate changes from baseline in serum fasting insulin values in each arm.
The need for insulin therapy
The need for insulin therapy in each arm
The number of Cesarean sections
The number of Cesarean sections in each arm
The mean birth-weight of newborns
The mean birth-weight of newborns in each arm

Full Information

First Posted
December 26, 2011
Last Updated
January 22, 2013
Sponsor
University of Turin, Italy
search

1. Study Identification

Unique Protocol Identification Number
NCT01506310
Brief Title
Efficacy of Behavioral Therapy and Exercise in Gestational Diabetes Mellitus (GDM)
Official Title
Randomized Comparative Trial on the Efficacy of Behavioral Therapy, Exercise and Their Combination in Gestational Diabetes Mellitus (GDM).
Study Type
Interventional

2. Study Status

Record Verification Date
January 2013
Overall Recruitment Status
Completed
Study Start Date
July 2009 (undefined)
Primary Completion Date
March 2012 (Actual)
Study Completion Date
June 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Turin, Italy

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to test whether four lifestyle intervention programs (diet alone; diet and behavioral therapy, diet and exercise, diet and behavioral therapy and exercise), delivered to women with GDM during 24-26 weeks of gestational age will help women to improve their metabolic pattern, and decrease the incidence of adverse maternal and neonatal outcomes.
Detailed Description
Women with gestational diabetes (GDM) are at increased risk of adverse pregnancy and neonatal outcomes. It is estimated that most women diagnosed with GDM can achieve targeted glycemic goals with nutrition therapy alone. A moderate exercise is recommended to lower serum glucose and to improve insulin sensitivity. Despite this, few reports examine the effect of exercise on glucose intolerance during pregnancy. Furthermore, no trial on the efficacy of behavioral treatment in women with GDM is available. The purpose of the study is to test whether four lifestyle intervention programs (diet alone; diet and behavioral therapy, diet and exercise, diet and behavioral therapy and exercise), delivered to women with GDM during 24-26 weeks of gestational age will help women to improve their metabolic pattern, and decrease the incidence of adverse maternal and neonatal outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Birth-weight
Keywords
gestational diabetes mellitus, fasting glucose, insulin resistance, birth-weight, Glucose values, Insulin concentrations, Cesarean sections

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Diet alone
Arm Type
No Intervention
Arm Title
Behavioral therapy
Arm Type
Experimental
Arm Title
Exercise
Arm Type
Experimental
Arm Title
Behavioral therapy and exercise
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Behavioral therapy
Intervention Description
General written dietary recommendations (about cooking, lowering sugar intake, reducing salt intake, reducing beverages and food with added sugars) and written options for dining out. A brief written guide on behavior change.
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
The exercise groups will be advised to walk at least 20-minute a day.
Intervention Type
Other
Intervention Name(s)
Behavioral therapy and exercise
Intervention Description
General written dietary recommendations (about cooking, lowering fat intake, reducing salt intake, reducing beverages and food with added sugars) and written options for dining out. Written recommendations for physical activity A brief written guide on behavior change
Primary Outcome Measure Information:
Title
Serum fasting glucose values.
Description
To investigate changes from baseline in serum fasting glucose values in each arm with a 2x2 factorial design.
Time Frame
Fasting glucose will be measured at recruitment (24 weeks of gestation) and at the end of follow-up (38 weeks of gestation)
Secondary Outcome Measure Information:
Title
Serum fasting insulin values
Description
To investigate changes from baseline in serum fasting insulin values in each arm.
Time Frame
At recruitment (at 24 weeks of gestation) and at the end of follow-up (38 weeks of gestation)
Title
The need for insulin therapy
Description
The need for insulin therapy in each arm
Time Frame
At recruitment and at the end of follow-up (38 weeks)
Title
The number of Cesarean sections
Description
The number of Cesarean sections in each arm
Time Frame
From recruitment until the date of delivery, either natural or by Caesarean section, assessed up to 42 weeks
Title
The mean birth-weight of newborns
Description
The mean birth-weight of newborns in each arm
Time Frame
From recruitment until the date of delivery, assessed up to 42 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Gestational age between 24 and 26 weeks Diagnosis of GDM at the 75g oral glucose tolerance test (OGTT) Singleton pregnancy Exclusion Criteria: Body mass index > 40 or < 12kg/m2 Any known diseases (pre-existing diabetes mellitus, cardiovascular diseases, liver/kidney diseases, cancers, arterial hypertension) Patients on any drugs
Facility Information:
Facility Name
University of Turin
City
Turin
ZIP/Postal Code
10126
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
25646328
Citation
Bo S, Gambino R, Menato G, Canil S, Ponzo V, Pinach S, Durazzo M, Ghigo E, Cassader M, Musso G. Isoleucine-to-methionine substitution at residue 148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes. Am J Clin Nutr. 2015 Feb;101(2):310-8. doi: 10.3945/ajcn.114.095125. Epub 2014 Dec 17.
Results Reference
derived
Links:
URL
http://www.epiclin.it
Description
site for randomization

Learn more about this trial

Efficacy of Behavioral Therapy and Exercise in Gestational Diabetes Mellitus (GDM)

We'll reach out to this number within 24 hrs